Inhibitors Influencing Carbohydrate Absorption

  • W. F. Caspary
Conference paper
Part of the Bayer AG Centenary Symposium book series (BAYER)

Abstract

Carbohydrates normally represent the majority of the human diet. As mono-, oligo- and, especially, polysaccharides, they form not only the greatest part quantitatively, but also the main energy supply. With a daily intake of 250–800 g, the average being slightly more than 300 g, in the Western industrialized countries dietary carbohydrates account for at least 50% of the daily calories in adults. On considering the different categories of carbohydrates (CHO), polysaccharides, represented almost exclusively by starch, are found to account for the major part. The oligosaccharides follow, the disaccharide sucrose representing quantitatively the most significant carbohydrate in this case. Monosaccharides play only a subordinate role as dietary components with regard to carbohydrate supply in man (Table 1) [1].

Keywords

Glycemic Index Brush Border Membrane Gastric Inhibitory Polypeptide Bacterial Fermentation Unstirred Layer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Elsenhans B, Caspary WF (1987) Absorption of carbohydrates. In: Caspary WF (ed) Structure and function of the small intestine. Excerpta Medica, Amsterdam, p 139Google Scholar
  2. 2.
    Caspary WF (1972) Evidence for a sodium-independent transport system for glucose derived from disaccharides. In: Heinz E (ed) Na-linked transport of organic solutes. Springer, Berlin, p 99CrossRefGoogle Scholar
  3. 3.
    Elsenhans B, Caspary WF (1983) Einfluß von Ballastoffen auf die Funktion des Dünndarms. In: Caspary WF (ed) Handbuch der Inneren Medizin, 5th edn, Vol3/part 3 A. Springer, Berlin, p. 567Google Scholar
  4. 4.
    Elsenhans B (1983) Pharmacology of carbohydrate gelling agents. In: Creutzfeldt W, Fölsch U (eds) Delaying absorption as a therapeutic principle in metabolic diseases. Thieme, Stuttgart, p 29Google Scholar
  5. 5.
    Elsenhans B, Caspary WF (1983) Resorption von Kohlenhydraten. In: Caspary WF (ed) Hand- buch der Inneren Medizin, 5th edn, vol 3/part 3 A. Springer, Berlin, p 139Google Scholar
  6. 6.
    Gray GM (1981) Carbohydrate absorption and malabsorption. In: Johnson LR (ed) Physiology of the gastrointestinal tract. Raven, New York, p 1063Google Scholar
  7. 7.
    Caspary WF (1987) Role of the colon in carbohydrate absorption and malabsorption. In: Caspary WF (ed) Structure and function of the small intestine. Excerpta Medica, Amsterdam, p 248Google Scholar
  8. 8.
    Englyst AN, Cummings JH (1985) Digestion of polysaccharides of some cereal foods in the human intestine. Am J Clin Nutr 42: 778–787PubMedGoogle Scholar
  9. 9.
    Conklin KA, Yamashiro KM, Gray GM (1975) Human intestinal sucrase-isomaltase: identification of free sucrase and isomaltase and cleavage of the hybrid into active distinct subunits. J Biol Chem 250: 5735PubMedGoogle Scholar
  10. 10.
    Crane RK, Miller D, Bihler I (1961) Restrictions on the possible mechanism of intestinal active transport of sugars. In: Kleinzeller A, Kotyk A (eds) Membrane transport and metabolism. Academic, New York, p 439Google Scholar
  11. 11.
    Crane RK (1962) Hypothesis of mechanism of intestinal active transport of sugars. Fed Proc 21: 891PubMedGoogle Scholar
  12. 12.
    Jenkins DJA, Wolever TMS, Taylor RH et al. (1981) Glycemic index of foods: a physiological basis for carbohydrate exchanges. Am J Clin Nutr 34: 362PubMedGoogle Scholar
  13. 13.
    Bo-Linn GW, Santa Ana CA, Morawski SG, Fordtran JS (1982) Starch blockers - their effect on caloric absorption from a high starch meal. N Engl J Med 307: 1413–1416PubMedCrossRefGoogle Scholar
  14. 14.
    Boivin M, Flourie B, Rizz RA, Go VLW, DiMagno EP (1988) Gastrointestinal and metabolic effects of amyolase inhibition in diabetics. Gastroenterology 94: 387–394PubMedGoogle Scholar
  15. 15.
    Müller L, Puis W (1987) Pharmacology of M-glucosidase inhibitors. In: Caspary WF (ed) Structure and function of the small intestine. Excerpta Medica, Amsterdam, p 281Google Scholar
  16. 16.
    Puis W, Keup U, Krause HP et al. (1977) Glucosidase inhibition. Naturwissenschaften 64: 536–537CrossRefGoogle Scholar
  17. 17.
    Caspary WF, Graf S (1979) Inhibition of -glucisidehydrolases by a new complex oligosaccharide. Res Exp Med 175: 1–6CrossRefGoogle Scholar
  18. 18.
    Caspary WF, Kalisch H (1979) Effect of C-glucosidehydrolase inhibition on intestinal absorption of sucrose, water, and sodium in man. Gut 20: 750–755PubMedCrossRefGoogle Scholar
  19. 19.
    Caspary WF (1978) Sucrose-malabsorption in man after ingestion of y-glucosidehydrolase inhibitor. Lancet I: 1231–1233CrossRefGoogle Scholar
  20. 20.
    Creutzfeldt W (ed) (1982) Proceedings of the first international symposium on acarbose. Excerpta Medica, AmsterdamGoogle Scholar
  21. 21.
    Creutzfeldt W, Fösch UR, Elsenhans B et al. (1985) Adaptation of the small intestine to induced maldigestion in rats. Scand J Gastroenterol [Suppl 112]: 45–53CrossRefGoogle Scholar
  22. 22.
    Fölsch UR, Ebert R, Creutzfeldt W (1981) Response of serum levels of gastric inhibitory polypeptide and insulin to sucrose ingestion during long-term application of acarbose. Scand J Gastroenterol 16: 629–632PubMedCrossRefGoogle Scholar
  23. 23.
    Fölsch UR, Lembcke B, Lücke H et al. (1984) Wirkung semisynthetischer Gliicosidaseinhibitoren (Bay o 1248 und m 1099) auf Glucose, GIP und Insulin im Serum nach oraler Saccharosegabe. Aktuel Endokrinol Stoffwechsel 5: 87 (Abstract)Google Scholar
  24. 24.
    Lembcke B, Fölsch UR, Gatzemeier W et al. (1985) Wirkung semisynthetischer L- Glucosidaseinhibitoren (Bay m 1099 und Bay o 1248) auf Blutglukose, Insulin und GIP im Serum sowie die H2 Exhalation nach wiederholter Stärkebelastung. Aktuel Endokrinol Stoffwechsel 6: 97 (Abstract)Google Scholar
  25. 25.
    Lembcke B, Fölsch UR, Creutzfeldt W (1985) Effect of 1-deoxynorojimycin derivatives on small intestinal disaccharidase activities and on active transport in vitro. Digestion 31: 120–127PubMedCrossRefGoogle Scholar
  26. 26.
    Lüllmann-Rauch R (1981) Lysosomal glycogen storage mimicking the cytological picture of Pompe’s disease as induced in rat by injection of an L-glucosidase inhibitor. I. Alterations in liver. Virchow’s Arch Abt B Cell Pathol 38: 89–100CrossRefGoogle Scholar
  27. 27.
    Lüllmann-Rauch R (1982) Lysosomal glycogen storage mimicking the cytological picture of Pompe’s disease as induced in rats by injection of an s-glucosidase inhibitor. II. Alterations in kidney, adrenal gland, spleen and soleus muscle. Virchow’s Arch Abt B Cell Pathol 39: 187–202CrossRefGoogle Scholar
  28. 28.
    Lembcke B, Wöhler J, Kirchhoff S, Creutzfeldt W (1986) Glycogen storage as a sequel of h-glucosidase inhibition. Eur J Clin Invest 16: A30 (Abstract)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • W. F. Caspary

There are no affiliations available

Personalised recommendations